Published in Law and Health Weekly, June 30th, 2007
Terameprocol, a synthetic tetra-methylated derivative of nordihydroguaiaretic acid (NDGA), is exclusively licensed by Erimos from The Johns Hopkins University for use in various diseases. Working at the DNA level, terameprocol is designed to prevent the production and activation of survivin, a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.